CN Mobile Logo


The US Food and Drug Administration (FDA) today announced that it has granted accelerated approval for Merck’s anti-PD-1 agent pembrolizumab (Keytruda) for treating patients with refractory metastatic non-small cell lung cancer (NSCLC) tumors that express programmed cell death protein ligand 1 (PD-L1).

A new risk assessment score more accurately reflects the probability of dying from chronic myeloid leukemia than do existing scoring systems.

A new genetic analysis found five new genetic variants that raise the risk for gliomas. One of the five was associated with a sharply increased risk for glioblastoma.

With the rollout of ICD-10 it's important to keep a sense of normalcy in other critical areas of your practice. Here are some ways to do that.

Medical students are actually calling their radiology rotation a “radiation vacation.”

The US Food and Drug Administration (FDA) has approved nivolumab (Opdivo) in combination with ipilimumab (Yervoy) for treating patients with BRAF V600 wild-type unresectable or metastatic melanoma.

A 57-year-old man presents with swelling of the scrotum. What is your diagnosis?


Subscribe to Cancer Network RSS

By clicking Accept, you agree to become a member of the UBM Medica Community.